Mechanism of Action
Androgen antagonists exert their effects by interfering with the binding of endogenous androgens to their cognate androgen receptors (AR). They operate primarily via two mechanisms:
-
Receptor Blockade: Many antiandrogens act as competitive inhibitors, binding directly to the androgen receptor. By occupying the receptor, these compounds prevent natural androgens from binding, thereby inhibiting their effects. The end result is an attenuation of androgen-mediated gene transcription and subsequent protein synthesis.
-
Inhibition of Androgen Synthesis: Some antiandrogens decrease the overall levels of circulating androgens by inhibiting enzymes crucial for androgen biosynthesis. By targeting key steps in the androgen synthesis pathway, these agents effectively reduce the overall levels of active androgens in the system.
Therapeutic applications
Androgen antagonists are mainly used for:
- Prostate Cancer Management: Given that many prostate cancers are androgen-sensitive, antiandrogens can slow down the growth of cancerous cells by depriving them of the androgens necessary for proliferation.
- Hirsutism: In women, antiandrogens can be employed to treat excessive hair growth caused by increased androgen activity.
- Polycystic Ovary Syndrome (PCOS): Some women with PCOS may benefit from antiandrogen therapies to address symptoms like acne or scalp hair thinning.
- Androgenic Alopecia: In cases of hair loss driven by androgens, certain antiandrogens can reduce the progression of thinning and balding.
Noteworthy Antiandrogens
Some well-established androgen antagonists include:
Bicalutamide
Flutamide
Spironolactone
Cyproterone Acetate
Enzalutamide
Ready to stop guessing?
Take the DNA test, get a topical formulated from your own results, and track it month by month in your dashboard.